Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Nutropin AQ (somatropin) injection is used for the treatment of children who have growth failure caused by growth hormone deficiency (GHD), idiopathic short stature (ISS), Turner syndrome (TS), and chronic kidney disease (CKD) up to the time of kidney transplantation.
Nutropin AQ is also for treating adults who have childhood-onset or adult-onset GHD.
Nutropin AQ is dispensed in pen cartridges and NuSpin forms:
Fact Table | |
---|---|
Formula | C990H1529N263O300S7 |
License | FDA approved |
Bioavailability | Approximately 70-90% (subcutaneous) |
Legal status | Prescription only |
Chemical Name | Somatropin |
Elimination half-life | Approximately 2-3 hours (subcutaneous) |
Dosage (Strength) | 5 mg/1.5 mL, 10 mg/2 mL, 20 mg/2 mL |
Pregnancy | Consult a healthcare provider |
Brands | Nutropin AQ, Genotropin, Humatrope, Norditropin |
Protein binding | Low |
PubChem CID | 16132348 |
MedlinePlus | a682922 |
ChEBI | 80612 |
ATC code | H01AC01 |
DrugBank | DB00052 |
KEGG | D04564 |
Routes of administration | Subcutaneous |
Use Nutropin AQ as your healthcare provider has directed. An appropriate treatment plan for you or your child, including Nutropin AQ dosage, will be decided by your healthcare provider based on weight and the condition requiring treatment. A healthcare professional should teach you or a caregiver on the proper storage, preparation, administration, and disposal of Nutropin AQ.
Nutropin AQ is given subcutaneously (underneath the skin) in the thigh, upper arm, abdomen, or buttocks. Be sure to rotate injection sites with each administration.
For product use information, refer to the medication guide that accompanies your prescription. Any questions or concerns may be referred to your healthcare provider or pharmacist.
Do not reuse or share needles and syringes with others.
Nutropin AQ cartridges and NuSpin injection devices are stable for 28 days after first use when stored in the refrigerator between 2°C-8°C (36°F-46°F); avoid freezing. Store out of light and away from children’s reach.
Somatropin is the active ingredient in Nutropin AQ.
Nutropin AQ should not be administered to patients with any of the following:
Nutropin AQ side effects include but are not limited to injection site reactions, swelling, edema, joint pain, and carpal tunnel syndrome. Notify the healthcare provider right away if you or child has side effects that become bothersome or persistent.
Here, you can buy Nutropin AQ!
Nutropin AQ. South San Francisco, CA: Genentech, Inc.; 2016.